Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.36 |
| ▸ | MMP9 | P14780 | 5/20 | 0.36 |
| ▸ | MMP8 | P22894 | 4/20 | 0.36 |
| ▸ | MMP13 | P45452 | 4/20 | 0.36 |
| ▸ | CNR1 | P21554 | 3/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16374270 | 1.00 | MMP2 (0.36) | MMP2MMP9MMP8MMP13CNR1 | |
| SCHEMBL11888315 | 0.94 | MMP2 (0.33) | MMP2MMP9MMP8MMP13CNR1 | |
| SCHEMBL14539246 | 0.92 | PDK2 (0.40) | MMP2MMP9MMP8MMP13PDK2 | |
| SCHEMBL15518483 | 0.92 | PDK2 (0.40) | MMP2MMP9MMP8MMP13PDK2 | |
| SCHEMBL21527512 | 0.92 | CNR1 (0.36) | MMP2MMP9MMP8MMP13CNR1 | |
| SCHEMBL14672099 | 0.92 | PDK2 (0.40) | MMP2MMP9MMP8MMP13PDK2 | |
| SCHEMBL13892122 | 0.92 | CNR1 (0.36) | MMP2MMP9MMP8MMP13CNR1 | |
| SCHEMBL12907949 | 0.91 | NPC1 (0.32) | MMP2MMP9MMP8MMP13CNR1 | |
| SCHEMBL15130538 | 0.89 | CNR1 (0.32) | MMP2MMP9MMP8MMP13CNR1 | |
| SCHEMBL12908759 | 0.87 | CNR2 (0.34) | MMP2MMP9MMP8MMP13CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170309826-A1 | WHITE-LIGHT HYPERBRANCHED CONJUGATED POLYMER, METHOD FOR PREPARING THE SAME AND IT'S USE | TAIYUAN UNIVERSITY OF TECHNOLOGY (CN) | 2017-10-26 | — | — | US | disclosed |
| US-20140350183-A1 | CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2014-11-27 | — | — | US | disclosed |
| US-20130018155-A1 | METAL COMPOSITES AND COMPOUND USEFUL FOR PREPARATION THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-17 | — | — | US | disclosed |
| WO-2009053089-A1 | OPTOELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018155-A1 | METAL COMPOSITES AND COMPOUND USEFUL FOR PREPARATION THEREOF | TERB1, TELO2, MRPS22 | MMP2 3445/4885MMP9 3404/4885MMP8 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.